Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 81–88 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
ABVC BioPharma Inc. ABV-1505 Attention Deficit Hyperactivity Disorder (ADHD) Phase 2a Enrollment Conclusion Oral Psychiatric
AC Immune SA Crenezumab - (CREAD 2) Alzheimer’s disease Phase 3 Trial Discontinued Intravenous Neurology
AC Immune SA Crenezumab - (CREAD 1) Alzheimer’s disease Phase 3 Trial Discontinued Intravenous Neurology
AC Immune SA Crenezumab - (API ADAD) Autosomal Dominant Alzheimer's Disease (ADAD) Phase 3 Ongoing Intravenous Genetic Disorder
AC Immune SA Crenezumab - (CREAD 2) Alzheimer’s disease Phase 3 Trial Discontinued Intravenous Neurology
AC Immune SA Crenezumab - (CREAD 1) Alzheimer’s disease Phase 3 Trial Discontinued Intravenous Neurology
AC Immune SA Crenezumab - (API ADAD) Autosomal Dominant Alzheimer's Disease (ADAD) Phase 3 Ongoing Intravenous Genetic Disorder
AC Immune SA PI-2620 - (ADvance) Alzheimer's disease Phase 3 Ongoing Intravenous Neurology